Add to ORKGOral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty: pooled analysis of two phase 3 randomized trial
Background—Dabigatran and rivaroxaban are novel oral anticoagulants approved for prevention of venou...
Background: The role of aspirin in thromboprophylaxis after total hip arthroplasty (THA) is controve...
Background: Anticoagulant prophylaxis substantially reduces the risk of venous thromboembolism (VTE)...
After hip replacement surgery, prophylaxis following discharge from hospital is recommended to reduc...
This trial compared the efficacy and safety of oral dabigatran, a direct thrombin inhibitor, versus ...
This trial compared the efficacy and safety of oral dabigatran, a direct thrombin inhibitor, versus ...
In the Re-NOVATE II study, oral dabigatran provided thromboprophylaxis after total hip arthroplasty ...
Dabigatran etexilate was recently approved by the Therapeutic Goods Administration for thromboprophy...
BACKGROUND Dabigatran and rivaroxaban are novel oral anticoagulants approved for prevention of venou...
SummaryObjectiveIn the Re-NOVATE II study, oral dabigatran provided thromboprophylaxis after total h...
<div><p class="abstract"><strong>BACKGROUND:</strong> Venous thromboembolism (VTE) and deep vein thr...
Background-Dabigatran and rivaroxaban are novel oral anticoagulants approved for prevention of venou...
BACKGROUND: Oral anticoagulants, such as dabigatran etexilate, an oral, direct thrombin inhibitor, ...
Objective: In the Re-NOVATE II study, oral dabigatran provided thromboprophylaxis after total hip ar...
Introduction: The risk of thromboembolic events for patients who have undergone a total hip arthropl...
Background—Dabigatran and rivaroxaban are novel oral anticoagulants approved for prevention of venou...
Background: The role of aspirin in thromboprophylaxis after total hip arthroplasty (THA) is controve...
Background: Anticoagulant prophylaxis substantially reduces the risk of venous thromboembolism (VTE)...
After hip replacement surgery, prophylaxis following discharge from hospital is recommended to reduc...
This trial compared the efficacy and safety of oral dabigatran, a direct thrombin inhibitor, versus ...
This trial compared the efficacy and safety of oral dabigatran, a direct thrombin inhibitor, versus ...
In the Re-NOVATE II study, oral dabigatran provided thromboprophylaxis after total hip arthroplasty ...
Dabigatran etexilate was recently approved by the Therapeutic Goods Administration for thromboprophy...
BACKGROUND Dabigatran and rivaroxaban are novel oral anticoagulants approved for prevention of venou...
SummaryObjectiveIn the Re-NOVATE II study, oral dabigatran provided thromboprophylaxis after total h...
<div><p class="abstract"><strong>BACKGROUND:</strong> Venous thromboembolism (VTE) and deep vein thr...
Background-Dabigatran and rivaroxaban are novel oral anticoagulants approved for prevention of venou...
BACKGROUND: Oral anticoagulants, such as dabigatran etexilate, an oral, direct thrombin inhibitor, ...
Objective: In the Re-NOVATE II study, oral dabigatran provided thromboprophylaxis after total hip ar...
Introduction: The risk of thromboembolic events for patients who have undergone a total hip arthropl...
Background—Dabigatran and rivaroxaban are novel oral anticoagulants approved for prevention of venou...
Background: The role of aspirin in thromboprophylaxis after total hip arthroplasty (THA) is controve...
Background: Anticoagulant prophylaxis substantially reduces the risk of venous thromboembolism (VTE)...